💪 #Novavax submitted its application to the FDA today for its updated #COVID19 #vaccine, which they report is active against current circulating variants, KP.2 and KP.3.
“Nonclinical data have demonstrated that Novavax's vax induces broad neutralization responses to JN.1 lineage viruses including those containing the F456L and R346T mutations, and to "FLiRT" & "FLuQE" variants.”👍
The co. intends to have doses in the U.S. for distribution by mid-July.
https://tinyurl.com/2we5mcdt
Carolyn Barber, MD /
npub17a…8ydzp
2024-06-15 00:21:46
Author Public Key
npub17aet92c7rt96vy82n33kckddwulf6ecygejwgu8669kj7367zg9sw8ydzpPublished at
2024-06-15 00:21:46Event JSON
{
"id": "370147b32c05202a926f34089e2c4ae45f9cb47b24a79bcb9aa200c06645f63d",
"pubkey": "f772b2ab1e1acba610ea9c636c59ad773e9d67044664e470fad16d2f475e120b",
"created_at": 1718410906,
"kind": 1,
"tags": [
[
"t",
"novavax"
],
[
"t",
"COVID19"
],
[
"t",
"Vaccine"
],
[
"proxy",
"https://med-mastodon.com/users/cbarbermd/statuses/112617777186285482",
"activitypub"
]
],
"content": "💪 #Novavax submitted its application to the FDA today for its updated #COVID19 #vaccine, which they report is active against current circulating variants, KP.2 and KP.3. \n\n“Nonclinical data have demonstrated that Novavax's vax induces broad neutralization responses to JN.1 lineage viruses including those containing the F456L and R346T mutations, and to \"FLiRT\" \u0026 \"FLuQE\" variants.”👍\n\nThe co. intends to have doses in the U.S. for distribution by mid-July. \n\nhttps://tinyurl.com/2we5mcdt",
"sig": "2248e309b2f8ae9a5d54bafd82c27e98721db90fc2964f283c5a8dce933f23983b7f748fed7aa491f73e4ef460b56edd0fc02ca6e3de9540708640a03790f7c1"
}